Discovery & Optimization of Novel GPCR Biologics for CV/Renal Disease
Time: 9:00 am
day: Day Two AM
Details:
- Development and optimization of the GEODe platform to overcome the structurally dynamic nature and biochemical instability of GPCRs
- Discovery of a GPCR agonist biologic clinically developed in a CV/renal disease indication
- Optimizing the potency, PK, and biophysical characteristics of lead biologic compounds
